Profiel
Patrik Ernfors is the founder of Glionova AB, where he currently holds the title of Director since 2014.
He was also a former Chief Scientific Officer at Global Genomics AB.
Actieve functies van Patrik Ernfors
Bedrijven | Functie | Begin |
---|---|---|
Glionova AB
Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Oprichter | 01-01-2014 |
Eerdere bekende functies van Patrik Ernfors
Bedrijven | Functie | Einde |
---|---|---|
Global Genomics AB
Global Genomics AB Miscellaneous Commercial ServicesCommercial Services Global Genomics AB used to discovers disease genes, drug targets and disease-associated biomarkers. It was also developing and out-licenses proprietary tools in functional genomics that provide insight into healthy, diseased or drug-treated cells. The company was founded by Patrik Ernfors & Sten Linnarsson in September, 2000 and was located in Stockholm, Sweden. | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Global Genomics AB
Global Genomics AB Miscellaneous Commercial ServicesCommercial Services Global Genomics AB used to discovers disease genes, drug targets and disease-associated biomarkers. It was also developing and out-licenses proprietary tools in functional genomics that provide insight into healthy, diseased or drug-treated cells. The company was founded by Patrik Ernfors & Sten Linnarsson in September, 2000 and was located in Stockholm, Sweden. | Commercial Services |
Glionova AB
Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Health Technology |